First Allied Advisory Services’s Orexigen Therapeutics, Inc. OREX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-2,660
| Closed | -$11K | – | 1142 |
|
|
2016
Q2 | $11K | Sell |
2,660
-45
| -2% | -$186 | ﹤0.01% | 1030 |
|
|
2016
Q1 | $13K | Sell |
2,705
-891
| -25% | -$4.28K | ﹤0.01% | 998 |
|
|
2015
Q4 | $59K | Sell |
3,596
-1,089
| -23% | -$17.9K | ﹤0.01% | 1070 |
|
|
2015
Q3 | $99K | Buy |
4,685
+629
| +16% | +$13.3K | 0.01% | 1003 |
|
|
2015
Q2 | $200K | Buy |
4,056
+166
| +4% | +$8.19K | 0.01% | 1029 |
|
|
2015
Q1 | $306K | Buy |
+3,890
| New | +$306K | 0.02% | 769 |
|